Skip to content

APOPARK: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOPARK

BE 0411.894.860
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€35,302
2024 · €53,977-€18,675
Equity
€157,479
2024 · €122,177+€35,302
Cash
€53,551
2024 · €61,817-€8,266
Balance sheet total
€210,821
2024 · €205,336+€5,485

Largest movements

2024 to 2025
Assets
  • Stocks and contracts +€12,148

    up €12,148 (+15.6%), from €77,742 to €89,890

  • Cash -€8,266

    down €8,266 (-13.4%), from €61,817 to €53,551

    mainly Other debts (-€39,638) and Stocks and contracts (-€12,148)

  • Receivables within one year +€6,002

    up €6,002 (+15.2%), from €39,376 to €45,378

    of which Other amounts receivable: +€5,878

  • Tangible fixed assets -€4,177

    down €4,177 (-19.4%), from €21,561 to €17,384

    of which Other tangible fixed assets: -€3,542

Equity and liabilities
  • Other debts -€39,638

    down €39,638 (-94.2%), from €42,073 to €2,435

  • Reserves +€35,302

    up €35,302 (+58.7%), from €60,177 to €95,479

    of which Distributable reserves: +€35,302

  • Accrued charges and deferred income +€6,261

    up €6,261 (+126.3%), from €4,956 to €11,217

  • Trade debts +€3,275

    up €3,275 (+12.3%), from €26,678 to €29,953

Income statement
  • Staff costs +€20,184

    up €20,184 (+29.4%), from €68,607 to €88,791

  • Taxes -€7,051

    down €7,051 (-34.0%), from €20,728 to €13,677

  • Gross operating margin -€2,595

    down €2,595 (-1.7%), from €155,106 to €152,511

  • Financial income -€2,301

    down €2,301 (-72.6%), from €3,169 to €867

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €53,977
Gross operating margin -€2,595
Staff costs -€20,184
Depreciation -€337
Other operating charges +€1,099
Financial income -€2,301
Financial charges -€1,408
Taxes +€7,051
Result 2025 €35,302

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€2,602
Investment -€5,664
Financing €0
Cash 2024 €61,817
Net result for the year +€35,302
Depreciation +€9,841
Stocks and contracts -€12,148
Receivables within one year -€6,002
Deferred charges and accrued income +€222
Trade debts +€3,275
Tax, wage and social debts +€284
Other debts -€39,638
Accrued charges and deferred income +€6,261
Investment in fixed assets (net) -€5,664
Cash 2025 €53,551
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €205,336 €210,821 +€5,485 +2.7%
Fixed assets 21/28 €21,561 €17,384 -€4,177 -19.4%
Tangible fixed assets 22/27 €21,561 €17,384 -€4,177 -19.4%
Plant, machinery and equipment 23 €1,603 €1,511 -€92 -5.7%
Furniture and vehicles 24 €11,629 €11,086 -€543 -4.7%
Other tangible fixed assets 26 €8,330 €4,788 -€3,542 -42.5%
Current assets 29/58 €183,775 €193,436 +€9,662 +5.3%
Stocks and contracts in progress 3 €77,742 €89,890 +€12,148 +15.6%
Stocks 30/36 €77,742 €89,890 +€12,148 +15.6%
Amounts receivable within one year 40/41 €39,376 €45,378 +€6,002 +15.2%
Trade receivables 40 €35,030 €35,153 +€124 +0.4%
Other amounts receivable 41 €4,347 €10,225 +€5,878 +135.2%
Cash at bank and in hand 54/58 €61,817 €53,551 -€8,266 -13.4%
Deferred charges and accrued income 490/1 €4,840 €4,617 -€222 -4.6%
Total equity and liabilities 10/49 €205,336 €210,821 +€5,485 +2.7%
Equity 10/15 €122,177 €157,479 +€35,302 +28.9%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €60,177 €95,479 +€35,302 +58.7%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Distributable reserves 133 €53,977 €89,279 +€35,302 +65.4%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €83,159 €53,342 -€29,817 -35.9%
Amounts payable within one year 42/48 €78,203 €42,124 -€36,079 -46.1%
Trade debts 44 €26,678 €29,953 +€3,275 +12.3%
Suppliers 440/4 €26,678 €29,953 +€3,275 +12.3%
Taxes, remuneration and social security 45 €9,453 €9,737 +€284 +3.0%
Taxes 450/3 €2,370 €423 -€1,947 -82.2%
Remuneration and social security 454/9 €7,082 €9,314 +€2,231 +31.5%
Other amounts payable 47/48 €42,073 €2,435 -€39,638 -94.2%
Accrued charges and deferred income 492/3 €4,956 €11,217 +€6,261 +126.3%
Remuneration, social security and pensions 62 €68,607 €88,791 +€20,184 +29.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €9,503 €9,841 +€337 +3.5%
Other operating charges 640/8 €1,499 €400 -€1,099 -73.3%
Gross operating margin 9900 €155,106 €152,511 -€2,595 -1.7%
Operating profit (loss) 9901 €75,497 €53,480 -€22,017 -29.2%
Financial income 75/76B €3,169 €867 -€2,301 -72.6%
Recurring financial income 75 €3,169 €867 -€2,301 -72.6%
Financial charges 65/66B €3,961 €5,369 +€1,408 +35.6%
Recurring financial charges 65 €3,961 €5,369 +€1,408 +35.6%
Profit (loss) for the period before taxes 9903 €74,705 €48,979 -€25,727 -34.4%
Income taxes 67/77 €20,728 €13,677 -€7,051 -34.0%
Profit (loss) for the period 9904 €53,977 €35,302 -€18,675 -34.6%
Profit (loss) for the period to be appropriated 9905 €53,977 €35,302 -€18,675 -34.6%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.